A Study on Sepsis Diagnostics Market
Browse 180 pages of research report on Global Sepsis Diagnostics Market @ http://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market-2943/
Sepsis can be defined as the body’s reaction to the fungal, bacterial, viral, or parasitic infection, which may further lead to systemic inflammatory reaction and organ dysfunction or organ failure. Sepsis is one of the most common causes of death in hospitalized patients. According to data revealed by the Centers for Disease Control and Prevention, sepsis affects around 800,000 people in the U.S. each year and it is the ninth leading cause of disease-related deaths in North America. Death can be as a result of hypotension, organ failure, high heart rate, and extreme body temperatures or due to a combination of these. It is more common in the elderly and infants.
The growth of Sepsis Diagnostics market is attributed to factors like rising prevalence of different antibiotic resistant bacterial strains, increasing geriatric population, growing number of surgical procedures, high incidence rates of hospital acquired infections and increasing number of product approvals. However, factors like lack of standard protocols, lack of awareness and death or skilled staff are likely to hamper the growth of the market.
Request Sample Market Brochure of the report @ http://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market-2943/request-sample
The Global market for Sepsis Diagnostics is segmented based on Pathogen, Product, Technology, Method and Usability. Based on Pathogen – Bacterial and Fungal. Based on Product - Instruments, Blood Culture Media, Assay Kits and Reagents. Based on Technology - Molecular Diagnostics, Microbiology, Immunoassay and Flow Cytometry. Based on Method – Conventional and Automated. Based on Usability - Laboratory and Point-of-care testing.
Based on the Geographical analysis the market is separated into regions of North America, Asia-Pacific, Europe, Latin America and Middle East and Africa. North America is leading the market while Europe is at second place.
Growing focus of stakeholders on research projects, drug discovery and diagnosis has helped North America dominate the market. Asia Pacific is expected to grow the fastest owing to number of factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players in this region.
Bacterial Sepsis Diagnostics have accounted for major share among the pathogen segment. Molecular Diagnostics is expected to grow the fastest among the technology segment. Blood culture media is regarded as the standard treatment procedure and holds the major share among the products segment.
Some of the key players dominating this market include bioMérieux SA, T2 Biosystem Inc, Cepheid, Thermo Fisher Scientific Inc., Nanosphere Inc, Abbott Laboratories, Roche Diagnostics Limited, Becton, Dickinson and Company, Bruker Corporation, and Beckman Coulter, Inc.
Make an Inquiry before buying @ http://www.marketdataforecast.com/market-reports/sepsis-diagnostics-market-2943/inquire
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release A Study on Sepsis Diagnostics Market here
News-ID: 771850 • Views: 339
More Releases from MDF
Beta-Glucan Market will grow at a CAGR of 7.32% during 2016 to 2021
The Global Beta-Glucan Market was worth USD 328.5 million in 2016 and estimated to be growing at a CAGR of 7.32%, to reach USD 467.67 million by 2021, According to a recent report published by Market Data Forecast. Check Report Details @ https://www.marketdataforecast.com/market-reports/global-beta-glucan-market-2395/ Market Overview: Increasing demand for processed and ready to eat food coupled with rising awareness about the nutritional value of functional food is expected to be the primary driver
Agrochemical Intermediates Market Outlook 2021 | Market Data Forecast
The Global Agrochemical Intermediates Market was worth USD XX.XX billion in 2016 and estimated to be growing at a CAGR of X.XX%, to reach USD XX.XX billion by 2021. Browse details of 185 pages research report on Global Agrochemical Intermediates Market @ http://www.marketdataforecast.com/market-reports/agrochemical-intermediates-market-4802/ Agrochemical Intermediates are widely used to manufacture pesticides such as insecticides, herbicides and fungicides. Common examples of agrochemical intermediates are 2-Chloro-5-Chloro Methyl Pyridine, Diethyl Phosphorochloridothionate, 2-Chloropropionic Acid,
A Glance at the new trends in the Active, Smart and Intelligent Packaging Indust …
Perspective is important, what one person might see as utility another sees as an opportunity. Having a personal tomato patch is quite different than farming tomatoes on land the size of Vatican, even though it gives out the same product, their number varies exponentially, the thought that is put into also varies widely, and at every step of the process there are different variables to take care of. This is
6.5% is an estimated growing CAGR for Vascular Imaging Market during 2016 to 202 …
According to the Global Vascular Imaging Market Research Report, the market is anticipated to grow at a 6.5% CAGR from 2016 to 2021 and it is estimated that the global market was valued at USD 4.35 billion in 2016 and is expected to reach USD 5.96 billion by 2021. Browse details of 175 pages research report on Global Vascular Imaging Market @ http://www.marketdataforecast.com/market-reports/vascular-imaging-market-5019/ Vascular imaging tests are used to assess how
More Releases for Diagnostics
Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Global Influenza Diagnostics Market 2017 : BioMerieux, SA Scientific, Enigma Dia …
Influenza Diagnostics Market 2017 A market study based on the " Influenza Diagnostics Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Influenza Diagnostics Market 2017’. The research report analyses the historical as well as present performance of the worldwide Influenza Diagnostics industry, and makes predictions on the future status of Influenza Diagnostics market on the basis of this analysis. Get Free Sample Copy of
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test